Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jun 1;177(6):1541-50.
doi: 10.1084/jem.177.6.1541.

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

Affiliations

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

S C Jameson et al. J Exp Med. .

Abstract

A previous report showed that the proliferative response of helper T cells to class II major histocompatibility complex (MHC)-restricted antigens can be inhibited by analogues of the antigen, which act as T cell receptor (TCR) antagonists. Here we define and analyze peptide variants that antagonize various functions of class I MHC-restricted cytotoxic T lymphocyte (CTL) clones. Of 64 variants at individual TCR contact sites of the Kb-restricted octamer peptide ovalbumin257-264 (OVAp), a very high proportion (40%) antagonized lysis by three OVAp-specific CTL clones. This effect was highly clone specific, since many antagonists for one T cell clone have differential effects on another. We show that this inhibition of CTL function is not a result of T cell-T cell interaction, precluding veto-like phenomena as a mechanism for antagonism. Moreover, we present evidence for direct interaction between the TCR and antagonist-MHC complexes. In further analysis of the T cell response, we found that serine esterase release and cytokine production are susceptible to TCR antagonism similarly to lysis. Ca2+ flux, an early event in signaling, is also inhibited by antagonists but may be more resistant to the antagonist effect than downstream responses.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1980 Oct 1;152(4):1036-47 - PubMed
    1. J Exp Med. 1993 Apr 1;177(4):1047-60 - PubMed
    1. Nature. 1985 Apr 25-May 1;314(6013):743-5 - PubMed
    1. J Immunol. 1986 Aug 1;137(3):952-61 - PubMed
    1. Annu Rev Immunol. 1988;6:115-37 - PubMed

Publication types

MeSH terms